Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Topical roflumilast formulation having improved delivery and plasma half life

Topical roflumilast formulation having improved delivery and plasma half life

US Patent 11129818 · Granted Sep 28, 2021

Estimated economic value: $19,563,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions of spironolactone for deep dermal drug delivery2025
Topical roflumilast aerosol foams2025
Method for reducing side effects from administration of phosphodiesterase-4 inhi2025
Inhibition of crystal growth of roflumilast2025
Topical roflumilast formulation having antifungal properties2025
Topical roflumilast formulation having improved delivery and plasma half-life2025
Inhibition of crystal growth of roflumilast2025
Roflumilast formulations with an improved pharmacokinetic profile2025
Pharmaceutical compositions of roflumilast and solvents capable of dissolving hi2024
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Methods for ophthalmic delivery of roflumilast2024
Laureth-4 containing topical formulations2024